# A Phase 2 Study of Radiprodil in Subjects With Drug-resistant Infantile Spasms (IS)

> **NCT02829827** · PHASE2 · TERMINATED · sponsor: **UCB Biopharma S.P.R.L.** · enrollment: 3 (actual)

## Conditions studied

- Infantile Spasms (IS)

## Interventions

- **DRUG:** Radiprodil

## Key facts

- **NCT ID:** NCT02829827
- **Lead sponsor:** UCB Biopharma S.P.R.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-12-04
- **Primary completion:** 2018-10-02
- **Final completion:** 2018-10-02
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** After reviewing the feasibility and projected completion date of the study, UCB has made the decision to stop the study
- **Last updated:** 2019-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02829827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02829827, "A Phase 2 Study of Radiprodil in Subjects With Drug-resistant Infantile Spasms (IS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02829827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*